Kaupinen Wes has filed 3 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 124603 shares of PALVELLA THERAPEUTICS, INC. ($PVLA) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | Kaupinen Wes | President and CEO | A | Stock Option (Right to Buy) | 124603 | $0.00 | 124,603.0000 | 11,836,490 | 9999.99% | 1.05% |
| Feb. 5, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | Kaupinen Wes | President and CEO | A | Non-Qualified Stock Option (right to buy) | 243831 | $0.00 | 243,831.0000 | 0 | 9999.99% | 0.00% |
| Dec. 13, 2024 | PALVELLA THERAPEUTICS, INC. | $PVLA | Kaupinen Wes | President and CEO | A | Stock Option (right to buy) | 417806 | $0.00 | 417,806.0000 | 0 | 9999.99% | 0.00% |